Last reviewed · How we verify

Carbetocin infusion — Competitive Intelligence Brief

Carbetocin infusion (Carbetocin infusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Oxytocin receptor agonist. Area: Obstetrics/Gynecology.

marketed Oxytocin receptor agonist Oxytocin receptor (OXTR) Obstetrics/Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

Carbetocin infusion (Carbetocin infusion) — Ciusss de L'Est de l'Île de Montréal. Carbetocin is a synthetic oxytocin analogue that binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Carbetocin infusion TARGET Carbetocin infusion Ciusss de L'Est de l'Île de Montréal marketed Oxytocin receptor agonist Oxytocin receptor (OXTR)
Oxytocin bolus or oxytocin infusion Oxytocin bolus or oxytocin infusion Stony Brook University marketed Oxytocin receptor agonist Oxytocin receptor (OXTR)
Standard Dose Synthetic Pitocin Standard Dose Synthetic Pitocin Weill Medical College of Cornell University marketed Oxytocin receptor agonist Oxytocin receptor (OXTR)
syntocinon nasal spray syntocinon nasal spray Rambam Health Care Campus marketed Oxytocin receptor agonist Oxytocin receptor (OXTR)
Carbetocin Short-infusion Carbetocin Short-infusion University Hospital, Basel, Switzerland marketed Oxytocin receptor agonist Oxytocin receptor
Oxytocin 4 mIU/mL Oxytocin 4 mIU/mL Assistance Publique - Hôpitaux de Paris marketed Oxytocin receptor agonist Oxytocin receptor (OXTR)
Oxytocin (High dose) Oxytocin (High dose) The University of Texas Medical Branch, Galveston marketed Oxytocin receptor agonist Oxytocin receptor (OXTR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Oxytocin receptor agonist class)

  1. Assistance Publique - Hôpitaux de Paris · 2 drugs in this class
  2. Ciusss de L'Est de l'Île de Montréal · 2 drugs in this class
  3. Stony Brook University · 2 drugs in this class
  4. The University of Texas Medical Branch, Galveston · 1 drug in this class
  5. University Hospital, Basel, Switzerland · 1 drug in this class
  6. Ain Shams Maternity Hospital · 1 drug in this class
  7. Weill Medical College of Cornell University · 1 drug in this class
  8. KU Leuven · 1 drug in this class
  9. Rambam Health Care Campus · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Carbetocin infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/carbetocin-infusion. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: